MDCX
Medicus Pharma·NASDAQ
--
--(--)
--
--(--)
MDCX Filings
Filing Date
Form Description
Form Type
2026-03-25
Form POS AM - Post-Effective amendments for registration statement
2026-03-25 ·
Form POS AM - Post-Effective amendments for registration statement
2026-03-25
Form POS AM - Post-Effective amendments for registration statement
2026-03-25 ·
Form POS AM - Post-Effective amendments for registration statement
2026-03-25
Form POS AM - Post-Effective amendments for registration statement
2026-03-25 ·
Form POS AM - Post-Effective amendments for registration statement
2026-03-25
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-03-25 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-03-25
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-03-25 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-03-25
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-03-25 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-03-25
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-03-25 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-03-25
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Financials
2026-03-25 · Financials
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026-03-06
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-03-06 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-03-06
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-03-06 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
